Fidelity Info Services (FIS) +3% from its launch in August (vs. the Russell 2000 down -1%). We conservatively assume this trend will normalize eventually. Beta measures the sensitivity of an investment to the movement of its benchmark. Represents total return, after fees, from Inception Date through August 2020. Volatility was left at 15.47%, however, over the last 30 days, the volatility rate increased by 17.94%, as shares sank -15.69% for the moving average over the last 20 days. The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 22801419 for the day, which was evidently higher, when compared to the average daily volumes of the shares. A unique strategy for those looking for alpha in a robo-advice platform, A unique risk-management style of personalized hedging, Competitively priced when compared to hedge fund alternatives, No financial planning or access to advisors, Actively managed by a fairly young CIO and investment team. Common stock shares were lifted by -54.66% during last recorded quarter. Hits 7% Following Win over Labor Laws, UBER’s Market Valuation Surpasses an All-time High, Beyond Meat Inc [BYND] is the Stock to Watch Today Ahead of Earnings. Past performance is no guarantee of future … This is nearly ~2x the market's return, and more than ~3x that of other advisors such as Betterment and Wealthfront. During the last month, 0 analysts gave the Titan Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating. Information provided by Titan Support is for informational and general educational purposes only and is not investment or financial advice. Titan’s performance and track record are clearly available on the website. All Titan performance results include the use of a personalized hedge for a hypothetical client with an “Aggressive” risk profile; clients with “Moderate” or “Conservative” risk profiles would have … Titan Pharmaceuticals Inc. (NASDAQ:TTNP) went down by -7.03% from its latest closing price compared to the recent 1-year high of $0.55. The recent victory of Proposition 22... BioLineRX Ltd was a big gainer last Friday and looks set to extend those gains today. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance. For deposits of $10,000 or more, 1% annually. Also, the investment strategy is clearly outlined and accessible to all new investors. The majority of Flagship co's continue to be massive beneficiaries of secular tailwinds accelerated by COVID-19. The shares increased approximately by 28.06% in the 7-day charts and went up by -12.04% in the period of the last 30 days. Instead, it aims for a strategy focused on investment returns and relative outperformance. Raw Stochastic average of Titan Pharmaceuticals Inc. in the period of last 50 days is set at 22.97%. Titan Flagship is now up +30% YTD through August, materially outperforming the S&P 500 index which is up +10%. Read more about that here. Account holdings are for illustrative purposes only and are not investment recommendations. Like Flagship, our winners won more than our losers lost (biggest gainer PLAN +31%, biggest loser CARG -9%). However, given that Titan is focused on investing directly in individual securities, there are minimal underlying-fund fees. See full disclosures. Before investing, consider your investment objectives and Titan’s fees. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. *The Normalized Benchmark is a method of comparing each account against a comparable asset allocation. The receivables turnover for the company is 2.55 and the total asset turnover is 0.31. After a stumble in the market that brought TTNP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.95% of loss for the given period. The entity has a beta of 0.0193, which indicates not very significant fluctuations relative to the market. Titan’s investment advisory services are available only to residents of the United States in jurisdictions where Titan is registered. A strong start for our small/mid cap portfolio focused on opportunistic investments off the beaten path. Click here to access the Options Profits Trading Guide now. According to the data provided on, the moving average of the company in the 100-day period was set at 0.2264, with a change in the price was noted -0.1990. Also, the investment strategy is clearly outlined and accessible to all new investors. For the last few days, the stock... Titan Pharmaceuticals Inc. (TTNP) Reveals an Earnings Mystery. We believe these types of businesses have the highest chance of delivering strong returns over the long run. The CIO Clay Gardner can be found sharing updates to the strategy in video form. Many brokerage firms have already submitted their reports for TTNP stocks, with Maxim Group repeating the rating for TTNP by listing it as a “Buy.” The predicted price for TTNP in the upcoming period, according to Maxim Group is $4 based on the research report published on June 26th of the previous year 2019. Hedge funds often cost around 2% in management fees and an additional 20% in performance fees. Any historical returns, expected returns, or probability projections, are hypothetical in nature and may not reflect actual future performance. Details can be found here. Titan Pharmaceuticals Inc. (TTNP) is on the roll with an average volume... Reasons Why Long-term Faith on Enable Midstream Partners LP (ENBL) Could Pay Off Investors, Roll up the Sleeves! As returns on the market increase, Titan Pharmaceuticals returns are expected to increase less than the market. Past performance is no guarantee of future results. Refer to Titan Invest’s Program Brochure for more information. Similar to the Access to Advisors category, Titan does not try to compete in Financial Planning. The 1-year high price for the company’s stock is recorded $0.5450 on 03/03/20, with the lowest value … The Chinese electric vehicle companies are having a great time as their sales are... Titan leads the market with the highest volume after the company enters into an agreement with JT Pharma to develop JT-09 Implant. Learn a direct approach to trading Futures that provides you with the techniques and the confidence you need to make consistent profits. Sign up today to receive free access and a guided tour through our program, PATH TO SUCCESS. Performance results were prepared by Titan Invest, and have not been compiled, reviewed or audited by an independent accountant. Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities. By using this website, you accept our Terms of Use and Privacy Policy. Brokerage services are provided to Titan Clients by Apex Clearing, an SEC registered broker-dealer and member FINRA/SIPC. All in all, Titan offers one of the most unique strategies we monitor. Get your money managed for 0% advisory fees when you refer friends. Revenue of the developer of payroll and human resources software... BYD Joins Nio and Xpeng in China EV car sales boom. Hits 7% Following Win over Labor Laws, UBER’s Market Valuation Surpasses an... BioLineRX Ltd [BLRX] Rallies after Positive Data on Cancer Treatment, Polar Power Inc [POLA] A Potentially Big Winner Short-Term, Muscle Maker GRIL Stock Soars Above 70% Followed by Acquisition of Manhattan Location, BOQI International Medical Spikes Above 100% After BIMI Revenue Increases by 1026% During Q2, Paycom Software (PAYC), Super Micro Computer (SMCI) Posted Beating Results, Expecting Growths Ahead, BYD Company Ltd (BYDDF) Electric Vehicles Car Sales Rise by 85% YoY, Titan Pharmaceuticals (TTNP) Surges 60% on Acquisition Deal with JT Pharmaceuticals, DraftKings Inc [DKNG] Gains Pre-Market after Extending Deal with MansionBet, Intel Corporation (INTC) Caught Off Guard Expecting Another Big Beat in Q3, Glencore CEO Says It is in Talks with Carmakers and Battery Makers about Nickel, Uber, Inc. ***For a limited time, we are offering a FREE CLASS. Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities. When the bell rang at previous close Pfizer Inc. (PFE) was down -1.63%, Time to Buy Beat-Down BigCommerce Holdings Inc. (BIGC) Stock? Please see Disclosures below regarding returns. Titan lacks some of the traditional features that we include in our review, such as tax-loss harvesting, asset location, and concentrated positions management. Its stock-selection process involves screening for the most commonly owned stocks at top hedge-funds and then conducting bottom-up research on those securities. 2019 YTD results are from 1/1/19 through 3/29/19. Buy, Sell Or Hold Titan Pharmaceuticals, Inc. At 0.1 - Marketing Sentinel, Sponsored content. By using this website, you accept our Terms of Use and Privacy Policy. Past performance is no guarantee of future results. By using this website, you accept our Terms of Use and Privacy Policy.

Maplestory Knuckles Bbb, 3 Mobile Australia, Hugo's Studio City Delivery, Codenames Rules Horsepaste, Handmade Japanese Knives Uk, Fonts Similar To Engravers Gothic, Virtual Crime Scene Investigation Game, Uc Berkeley Global Studies Ranking, Fm Transmitter Keeps Disconnecting,